sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks 1,2,3,4-Tetrahydro-1,8-naphthyridine

1,2,3,4-Tetrahydro-1,8-naphthyridine

CAS No.:
13623-87-5
Catalog Number:
AG003D9W
Molecular Formula:
C8H10N2
Molecular Weight:
134.1784
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
250mg
96%
In Stock USA
United States
$69
- +
1g
96%
In Stock USA
United States
$207
- +
5g
96%
In Stock USA
United States
$663
- +
Product Description
Catalog Number:
AG003D9W
Chemical Name:
1,2,3,4-Tetrahydro-1,8-naphthyridine
CAS Number:
13623-87-5
Molecular Formula:
C8H10N2
Molecular Weight:
134.1784
MDL Number:
MFCD08234598
IUPAC Name:
1,2,3,4-tetrahydro-1,8-naphthyridine
InChI:
InChI=1S/C8H10N2/c1-3-7-4-2-6-10-8(7)9-5-1/h1,3,5H,2,4,6H2,(H,9,10)
InChI Key:
ZCZVGQCBSJLDDS-UHFFFAOYSA-N
SMILES:
C1CNc2c(C1)cccn2
Properties
Complexity:
114  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
134.084g/mol
Formal Charge:
0
Heavy Atom Count:
10  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
134.182g/mol
Monoisotopic Mass:
134.084g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
24.9A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.6  
Literature
Title Journal
Dihydro-pyrano[2,3-b]pyridines and tetrahydro-1,8-naphthyridines as CB1 receptor inverse agonists: synthesis, SAR and biological evaluation. Bioorganic & medicinal chemistry letters 20100615
Methods for the synthesis of 5,6,7,8-tetrahydro-1,8-naphthyridine fragments for alphaVbeta3 integrin antagonists. The Journal of organic chemistry 20041210
Nonpeptide alpha V beta 3 antagonists. Part 10: In vitro and in vivo evaluation of a potent 7-methyl substituted tetrahydro-[1,8]naphthyridine derivative. Bioorganic & medicinal chemistry letters 20040906
Non-peptide alpha v beta 3 antagonists. Part 7: 3-Substituted tetrahydro-naphthyridine derivatives. Bioorganic & medicinal chemistry letters 20040223
Identification of oxidative degradates of the TRIS salt of a 5,6,7,8-tetrahydro-1,8-naphthyridine derivative by LC/MS/MS and NMR spectroscopy--interactions between the active pharmaceutical ingredient and its counterion. Journal of pharmaceutical and biomedical analysis 20031204
Cascade cyclizations via N,4-didehydro-2-(phenylamino)pyridine biradicals/zwitterions generated from enyne-carbodiimides. The Journal of organic chemistry 20030711
Nonpeptide alpha(v)beta(3) antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptide. Bioorganic & medicinal chemistry letters 20020107
Properties